PROXIMA Trademark

Trademark Overview


On Friday, July 12, 2024, a trademark application was filed for PROXIMA with the United States Patent and Trademark Office. The USPTO has given the PROXIMA trademark a serial number of 98645946. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Wednesday, March 5, 2025. This trademark is owned by Proxima Health, Inc.. The PROXIMA trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Medical services, namely, providing patients with extracorporeal blood treatments, including for longevity and for disease treatment; Medical services, namely, blood filtration services performed on patients, including for removing microplastics, forever chemicals, heavy metals, environmental toxins, inflammatory markers, and pathogenic and other disease-promoting substances from the blood and body; Medical advisory and medical consultancy services in the field of extracorporeal blood treatments and blood filtration for medical purposes, including on the use and operation of plasmapheresis devices and other blood filtration devices; Leasing of medical equipment, namely, plasmapheresis devices and other blood filtration devices; Providing a website featuring medical and health information about extracorporeal blood treatments and blood filtration
proxima

General Information


Serial Number98645946
Word MarkPROXIMA
Filing DateFriday, July 12, 2024
Status661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED
Status DateWednesday, March 5, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesMedical services, namely, providing patients with extracorporeal blood treatments, including for longevity and for disease treatment; Medical services, namely, blood filtration services performed on patients, including for removing microplastics, forever chemicals, heavy metals, environmental toxins, inflammatory markers, and pathogenic and other disease-promoting substances from the blood and body; Medical advisory and medical consultancy services in the field of extracorporeal blood treatments and blood filtration for medical purposes, including on the use and operation of plasmapheresis devices and other blood filtration devices; Leasing of medical equipment, namely, plasmapheresis devices and other blood filtration devices; Providing a website featuring medical and health information about extracorporeal blood treatments and blood filtration

Classification Information


International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, July 12, 2024
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameProxima Health, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressAustin, TX 78703

Trademark Events


Event DateEvent Description
Friday, July 12, 2024NEW APPLICATION ENTERED
Tuesday, September 24, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, September 24, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, September 24, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, September 24, 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Thursday, November 21, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, November 21, 2024ASSIGNED TO LIE
Monday, February 3, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, February 4, 2025ASSIGNED TO EXAMINER
Thursday, February 13, 2025NON-FINAL ACTION WRITTEN
Thursday, February 13, 2025NON-FINAL ACTION E-MAILED
Thursday, February 13, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, March 4, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, March 4, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, March 5, 2025TEAS/EMAIL CORRESPONDENCE ENTERED